معرفی
Adam Bryce serves as an Honorary Clinical Lecturer within the School of Cancer Sciences at the University of Glasgow, based at the Wolfson Wohl Cancer Research Centre on Garscube Campus. His academic affiliation is non-salaried (honorary), indicating clinical practice alongside academic contributions.
His research focuses on pancreatic cancer biology and surgical oncology, with particular emphasis on tumor microenvironment dynamics, cancer-associated fibroblasts, and clinical management challenges. Recent work explores neoadjuvant therapy responses, molecular landscapes of early-onset disease, and surgical decision-making complexities in pancreatic ductal adenocarcinoma.
Analysis of his 8 publications (2014-2024) reveals a consistent trajectory in gastrointestinal oncology, evolving from colorectal tumor localization techniques to sophisticated pancreatic cancer microenvironment investigations. Key thematic threads include stromal-tumor interactions, surgical innovation in obstructive pathologies, and molecular determinants of resectability.
Scientific Recognition:
- Beatson Cancer Charity Research Grant (2023-2025) for investigating cancer-associated fibroblasts in pancreatic tumor-host interactions
Bryce maintains active clinical-academic integration through collaborations with major oncology consortia including the Australian Pancreatic Cancer Genome Initiative. His work bridges laboratory insights with surgical practice, particularly evident in recent presentations at the International Hepato-Pancreato-Biliary Association and European Society of Surgical Oncology congresses. Current research directions focus on phenotypic adversity metrics for resection prediction and molecular characterization of early-onset pancreatic cancer.
Based at the Wolfson Wohl Cancer Research Centre, he operates within Glasgow's integrated cancer research ecosystem, contributing to translational oncology through both clinical service characterizations and fundamental tumor biology investigations.